Highly malignant tumor variants retain tumor-specific antigens recognized by T helper cells

doi:10.1084/jem.164.5.1547

This Article

	Full Text (PDF, 1310K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Van Waes, C.
	Articles by Schreiber, H.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Van Waes, C.
	Articles by Schreiber, H.


Social Bookmarking

	What's this?

ARTICLES

Highly malignant tumor variants retain tumor-specific antigens recognized by T helper cells

C Van Waes, JL Urban, JL Rothstein, PL Ward and H Schreiber

We have studied the components of a complex of tumor-specific antigens to determine if all of the components of the complex were lost during progression from a rather benign regressor tumor to a highly malignant (HM) cancer. We find that the HM tumor cells have lost antigens recognized by CTL but retained antigens recognized by Th cells. Immunization with variants expressing Th-defined antigens induced tumor- specific immunity to challenge with a parental variant that expressed a CTL-recognized target antigen, but did not induce immunity to challenge with the variant that expressed the Th-defined antigen alone. Together, these findings suggested that Th cells fail to exert direct selective pressure upon the tumor, resulting in retention of "lineage-specific," Th-recognized antigens by highly immunoselected variants. Possible advantage could be taken of this fact for the development of specific immunotherapy.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Hess, S. D., Egilmez, N. K., Bailey, N., Anderson, T. M., Mathiowitz, E., Bernstein, S. H., Bankert, R. B. (2003). Human CD4+ T Cells Present Within the Microenvironment of Human Lung Tumors Are Mobilized by the Local and Sustained Release of IL-12 to Kill Tumors In Situ by Indirect Effects of IFN-{gamma}. J. Immunol. 170: 400-412 [Abstract] [Full Text]
Kass, E. S., Greiner, J. W., Kantor, J. A., Tsang, K. Y., Guadagni, F., Chen, Z., Clark, B., Pascalis, R. D., Schlom, J., Van Waes, C. (2002). Carcinoembryonic Antigen as a Target for Specific Antitumor Immunotherapy of Head and Neck Cancer. Cancer Res. 62: 5049-5057 [Abstract] [Full Text]
Egilmez, N. K., Hess, S. D., Chen, F.-A., Takita, H., Conway, T. F., Bankert, R. B. (2002). Human CD4+ Effector T Cells Mediate Indirect Interleukin-12- and Interferon-{gamma}-dependent Suppression of Autologous HLA-negative Lung Tumor Xenografts in Severe Combined Immunodeficient Mice. Cancer Res. 62: 2611-2617 [Abstract] [Full Text]
Beck-Engeser, G. B., Monach, P. A., Mumberg, D., Yang, F., Wanderling, S., Schreiber, K., Espinosa, R. III, Le Beau, M. M., Meredith, S. C., Schreiber, H. (2001). Point Mutation in Essential Genes with Loss or Mutation of the Second Allele: Relevance to the Retention of Tumor-Specific Antigens. JEM 194: 285-300 [Abstract] [Full Text]
Mumberg, D., Monach, P. A., Wanderling, S., Philip, M., Toledano, A. Y., Schreiber, R. D., Schreiber, H. (1999). CD4+ T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma. Proc. Natl. Acad. Sci. USA 96: 8633-8638 [Abstract] [Full Text]
Rohrer, J. W., Barsoum, A. L., Dyess, D. L., Tucker, J. A., Coggin, J. H. Jr. (1999). Human Breast Carcinoma Patients Develop Clonable Oncofetal Antigen-Specific Effector and Regulatory T Lymphocytes. J. Immunol. 162: 6880-6892 [Abstract] [Full Text]